Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Relevance of vertical growth pattern in thin level II cutaneous superficial spreading melanomas.

Lefevre M, Vergier B, Balme B, Thiebault R, Delaunay M, Thomas L, Beylot-Barry M, Machet L, De Muret A, Bioulac-Sage P, Bailly C.

Am J Surg Pathol. 2003 Jun;27(6):717-24.

PMID:
12766575
2.

Clinicopathologic features and behavior of cutaneous eyelid melanoma.

Vaziri M, Buffam FV, Martinka M, Oryschak A, Dhaliwal H, White VA.

Ophthalmology. 2002 May;109(5):901-8.

PMID:
11986095
3.

Prognostic factors in thin cutaneous malignant melanoma.

Månsson-Brahme E, Carstensen J, Erhardt K, Lagerlöf B, Ringborg U, Rutqvist LE.

Cancer. 1994 May 1;73(9):2324-32.

4.

Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.

Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N.

Cancer. 1996 Apr 1;77(7):1303-10.

5.

Thin cutaneous malignant melanomas (< or =1.5 mm): identification of risk factors indicative of progression.

Massi D, Franchi A, Borgognoni L, Reali UM, Santucci M.

Cancer. 1999 Mar 1;85(5):1067-76.

PMID:
10091790
6.

The correlation of regression in primary melanoma with sentinel lymph node status.

Kaur C, Thomas RJ, Desai N, Green MA, Lovell D, Powell BW, Cook MG.

J Clin Pathol. 2008 Mar;61(3):297-300. Epub 2007 Aug 3.

PMID:
17675538
7.

Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.

Måsbäck A, Westerdahl J, Ingvar C, Olsson H, Jonsson N.

Cancer. 1997 Jan 15;79(2):275-83.

PMID:
9010101
8.
9.

Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.

Schmid-Wendtner MH, Baumert J, Eberle J, Plewig G, Volkenandt M, Sander CA.

Br J Dermatol. 2003 Oct;149(4):788-93.

PMID:
14616371
10.

[Is acrolentiginous melanoma (ALM) more malignant than superficially spreading melanoma (SSM) at a high-risk site? A matched-pair comparison between 113 ALM and SSM within the scope of a multicenter study].

Breuninger H, Köhler C, Drepper H, Bastian B, Bröcker EB, Göhl J, Groth W, Hermanek P, Hohenberger W, Lippold A, et al.

Hautarzt. 1994 Aug;45(8):529-31. German.

PMID:
7960751
11.

Problems in the interpretation of apparent "radial growth phase" malignant melanomas that metastasize.

Abramova L, Slingluff CL Jr, Patterson JW.

J Cutan Pathol. 2002 Aug;29(7):407-14.

PMID:
12139635
12.

Cutaneous melanomas that defy conventional prognostic indicators.

McCarthy WH, Shaw HM, McCarthy SW, Rivers JK, Thompson JF.

Semin Oncol. 1996 Dec;23(6):709-13.

PMID:
8970591
13.

Thin melanomas.

King R, Googe PB, Mihm MC Jr.

Clin Lab Med. 2000 Dec;20(4):713-29. Review.

PMID:
11221511
14.
15.

[Histopathologic classification of malignant melanoma of the skin. Retrospective study of 149 cases].

Hauser C, Gloor F.

Schweiz Med Wochenschr. 1979 Feb 3;109(5):152-7. German.

PMID:
441722
16.

Clinical features of superficial spreading melanomas with zones of regression.

Czarnetzki BM, Denter M, Bröcker EB, Rümke P, Krieg V, Vakilzadeh F, Macher E.

J Cancer Res Clin Oncol. 1984;107(3):225-8.

PMID:
6736111
17.
18.

Histopathologic study of recurrent Clark level II melanomas.

Glass LF, Guffey JM, Schroer KR, Reintgen D.

Semin Surg Oncol. 1993 May-Jun;9(3):202-7.

PMID:
8516604
19.

Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent.

Guerry D 4th, Synnestvedt M, Elder DE, Schultz D.

J Invest Dermatol. 1993 Mar;100(3):342S-345S.

PMID:
8440920
Items per page

Supplemental Content

Write to the Help Desk